Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.6300 (1.37%) ($9.6300 - $9.6300) on Fri. Jun. 2, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.78% (three month average) | RSI | 52 | Latest Price | $9.6300(1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 1.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(63%) IBB(49%) IWC(48%) IWO(45%) IWM(44%) | Factors Impacting EDIT price | EDIT will decline at least -2.39% in a week (0% probabilities). IGOV(-15%) TBT(-12%) UUP(-7%) UNG(-7%) VIXM(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.39% (StdDev 4.78%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $9.27(3.88%) | 10 Day Moving Average | $9.35(2.99%) | 20 Day Moving Average | $9.53(1.05%) | To recent high | -6.7% | To recent low | 51.5% | Market Cap | $598m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |